Well, my company is finally catching some break in the stock market. But two sad things about this very positive news:
- We still have to wait for FDA approval next year
- I won’t become rich even if our prostate cancer drug’s approved - I’m just a scientist, what’d you expect?
But hey, still making a little money on paper feels way better than nothing! 